Deadline to submit is Feb. 19
OncLive®, the leading digital provider of resources and information to oncology professionals, is accepting abstract submissions through Feb. 19 for the National Fellows Forum: Gyn-Onc. The forum serves as an educational platform that promotes collaboration among fellows, medical professionals, researchers and clinicians.
“We are thrilled with the flow of submissions we have received so far,” said Michael J. Hennessy Jr., president of Michael J. Hennessy Associates, parent company of OncLive®. “We look forward to gathering the topmost upcoming oncology professionals to discuss their significant research and contributions to the field of gynecologic oncology.”
Each submission will be reviewed by a board of 10 esteemed faculty members, led by Mario M. Leitao, Jr, MD, FACOG, FACS of Memorial Sloan Kettering Cancer Center The faculty will then select 50 fellows to attend the National Fellow Forum: Gyn-Onc in Miami, Florida, from April 26-28, based on the following criteria: novelty of research, significance of findings, relevance to gynecologic oncology and clarity.
“We are delighted to work with the future leaders in gynecologic oncology,” said Robert Goldsmith, vice president of OncLive®. “Through this initiative, we look forward to connecting with tomorrow’s leaders within the Gyn-Onc community.”
For more information and to submit an abstract, visit www.onclive.com/oncfellows-forum or contact Allison Cooper at acooper@curetoday.com.
OncLive®
A digital platform of resources for practicing oncologists, OncLive® offers oncology professionals information they can use to help provide the best patient care. OncLive.com is the official website for Michael J. Hennessy Associates’ Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News®, and more. Michael J. Hennessy Associates, Inc., is a full-service health care communications company offering education, research and medical media, including curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups. http://www.giantsofcancercare.com/nominate.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180212006014/en/
OncLive® Press:
Theresa Burek,
609-325-4811
tburek@mjhassoc.com
or
Surabhi
Verma, 609-716-7777
Sverma@mjhassoc.com